Oxurion
Gaston Geenslaan 1
3001 Leuven
BE
Oxurion
Foundation date
30/05/2006
Sector
#Biotechnology - TherapeuticsSubsector
- #Therapeutics - Drug delivery
- #Therapeutics - Peptides
- #Therapeutics - Proteins
- #Therapeutics - Small molecules
- #Therapeutics - Antibodies
Therapeutic areas
Oxurion is dedicated to developing and commercializing new pharmacologic ophthalmic treatments that address important unmet clinical needs. By meeting this goal Oxurion intends to help patients around the world with a new or better treatment for their condition.
Upcoming events
All events-
0712 '22
Emerging Applications of Microbes (2nd edition)
Event by: VIB -
1212 '22
Type 2 Immunity in Homeostasis and Disease (2nd edition)
Event by: VIB -
2911 '22
BioFIT 2022
Event by: Eurasanté
Latest news
More news-
Galapagos receives positive CHMP opinion for Jyseleca® European label update based on testicular function safety data from MANTA/RAy studies
14 hours ago
Read more
-
Indigo Diabetes announces first participant enrolled in the SHINE clinical trial
Thursday September 29th 2022
Read more
-
FINTEPLA®▼ (fenfluramine) approved in Japan for the treatment of seizures associated with Dravet syndrome
Tuesday September 27th 2022
Read more